Literature DB >> 19490627

Haptoglobin genotype is a determinant of survival and cardiac remodeling after myocardial infarction in diabetic mice.

Roy Asaf1, Shany Blum, Ariel Roguin, Shiri Kalet-Litman, Jad Kheir, Avi Frisch, Rachel Miller-Lotan, Andrew P Levy.   

Abstract

BACKGROUND: We have recently demonstrated in man that a functional allelic polymorphism in the Haptoglobin (Hp) gene plays a major role in determining survival and congestive heart failure after myocardial infarction (MI). We sought to recapitulate the effect of Hp type on outcomes and cardiac remodeling after MI in transgenic mice.
METHODS: The Hp 2 allele exists only in man. Wild type C57Bl/6 mice carry the Hp 1 allele with high homology to the human Hp 1 allele. We genetically engineered a murine Hp 2 allele and targeted its insertion by homologous recombination to the murine Hp locus to create Hp 2 mice. Diabetes Mellitus (DM) was induced with streptozotocin. MI was produced by occlusion of the left anterior descending artery in DM C57Bl/6 mice carrying the Hp 1 or Hp 2 allele. MI size was determined with TTC staining. Left ventricular (LV) function and dimensions were assessed by 2-dimensional echocardiography.
RESULTS: In the absence of DM, Hp 1-1 and Hp 2-2 mice had similar LV dimensions and LV function. MI size was similar in DM Hp 1-1 and 2-2 mice 24 hours after MI (50.2 +/- 2.1%and 46.9 +/- 5.5%, respectively, p = 0.6). However, DM Hp 1-1 mice had a significantly lower mortality rate than DM Hp 2-2 mice 30 days after MI (HR 0.41, 95% CI (0.19-0.95), p = 0.037 by log rank). LV chamber dimensions were significantly increased in DM Hp 2-2 mice compared to DM Hp 1-1 mice 30 days after MI (0.196 +/- 0.01 cm2 vs. 0.163 +/- 0.01 cm2, respectively; p = 0.029).
CONCLUSION: In DM mice the Hp 2-2 genotype is associated with increased mortality and more severe cardiac remodeling 30 days after MI.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19490627      PMCID: PMC2694779          DOI: 10.1186/1475-2840-8-29

Source DB:  PubMed          Journal:  Cardiovasc Diabetol        ISSN: 1475-2840            Impact factor:   9.951


  21 in total

Review 1.  CD163: a signal receptor scavenging haptoglobin-hemoglobin complexes from plasma.

Authors:  Jonas Heilskov Graversen; Mette Madsen; Søren K Moestrup
Journal:  Int J Biochem Cell Biol       Date:  2002-04       Impact factor: 5.085

2.  Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.

Authors:  I M Stratton; A I Adler; H A Neil; D R Matthews; S E Manley; C A Cull; D Hadden; R C Turner; R R Holman
Journal:  BMJ       Date:  2000-08-12

3.  Haptoglobin genotype determines myocardial infarct size in diabetic mice.

Authors:  Shany Blum; Roy Asaf; Julia Guetta; Rachel Miller-Lotan; Rabea Asleh; Ran Kremer; Nina S Levy; Franklin G Berger; Doron Aronson; Xiaoming Fu; Renliang Zhang; Stanley L Hazen; Andrew P Levy
Journal:  J Am Coll Cardiol       Date:  2006-12-13       Impact factor: 24.094

4.  Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The Strong Heart Study.

Authors:  Andrew P Levy; Irit Hochberg; Kathleen Jablonski; Helaine E Resnick; Elisa T Lee; Lyle Best; Barbara V Howard
Journal:  J Am Coll Cardiol       Date:  2002-12-04       Impact factor: 24.094

5.  Cardiovascular morbidity and early mortality cluster in parents of type 1 diabetic patients with diabetic nephropathy.

Authors:  L Tarnow; P Rossing; F S Nielsen; J A Fagerudd; O Poirier; H H Parving
Journal:  Diabetes Care       Date:  2000-01       Impact factor: 19.112

6.  Acute-phase protein haptoglobin is a cell migration factor involved in arterial restructuring.

Authors:  Dominique P V de Kleijn; Mirjam B Smeets; Patrick P C W Kemmeren; Sai K Lim; Ben J Van Middelaar; Evelyn Velema; Arjan Schoneveld; Gerard Pasterkamp; Cornelius Borst
Journal:  FASEB J       Date:  2002-05-21       Impact factor: 5.191

7.  Identification of the haemoglobin scavenger receptor.

Authors:  M Kristiansen; J H Graversen; C Jacobsen; O Sonne; H J Hoffman; S K Law; S K Moestrup
Journal:  Nature       Date:  2001-01-11       Impact factor: 49.962

Review 8.  Cardiovascular disease in diabetes mellitus type 2: a potential role for novel cardiovascular risk factors.

Authors:  J M Hayden; P D Reaven
Journal:  Curr Opin Lipidol       Date:  2000-10       Impact factor: 4.776

9.  Haptoglobin expression and activity during coronary collateralization.

Authors:  Nicole L Lohr; David C Warltier; William M Chilian; Dorothee Weihrauch
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-11-18       Impact factor: 4.733

10.  Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial.

Authors:  Uzi Milman; Shany Blum; Chen Shapira; Doron Aronson; Rachel Miller-Lotan; Yefim Anbinder; Junia Alshiek; Lawrence Bennett; Maria Kostenko; Michele Landau; Shlomo Keidar; Yishai Levy; Alexander Khemlin; Arman Radan; Andrew P Levy
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-11-21       Impact factor: 8.311

View more
  5 in total

Review 1.  Haptoglobin genotype and its role in determining heme-iron mediated vascular disease.

Authors:  Hagit Goldenstein; Nina S Levy; Andrew P Levy
Journal:  Pharmacol Res       Date:  2012-03-23       Impact factor: 7.658

2.  Quantitative digital in situ senescence-associated β-galactosidase assay.

Authors:  Liran I Shlush; Shalev Itzkovitz; Ariel Cohen; Aviad Rutenberg; Ron Berkovitz; Shiran Yehezkel; Hofit Shahar; Sara Selig; Karl Skorecki
Journal:  BMC Cell Biol       Date:  2011-04-15       Impact factor: 4.241

3.  Haptoglobin genotype predicts development of coronary artery calcification in a prospective cohort of patients with type 1 diabetes.

Authors:  Melissa Simpson; Janet K Snell-Bergeon; Gregory L Kinney; Orit Lache; Rachel Miller-Lotan; Yefim Anbinder; Marian J Rewers; Andrew P Levy
Journal:  Cardiovasc Diabetol       Date:  2011-11-20       Impact factor: 9.951

4.  The transcriptomic profile of peripheral blood nuclear cells in dogs with heart failure.

Authors:  Magdalena Hulanicka; Magdalena Garncarz; Marta Parzeniecka-Jaworska; Michał Jank
Journal:  BMC Genomics       Date:  2014-06-21       Impact factor: 3.969

5.  Haptoglobin genotype and risk markers of cardiovascular disease in patients with chronic kidney disease.

Authors:  Charlotte Strandhave; My Svensson; Henrik Krarup; Jeppe Hagstrup Christensen
Journal:  Int J Nephrol       Date:  2013-03-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.